Stock On the Run: TransEnterix, Inc. (NYSE:TRXC)

TransEnterix, Inc. (NYSE:TRXC)

BTIG Research Downgrades TransEnterix, Inc. (NYSE:TRXC)’s stock to Neutral with no specific Price Target. This rating was issued on 6/28/18. The stock recently closed its previous session at $4.5 by showing a percentage change of -1.53% from its previous day closing price of $4.57.

Price Target is basically a projection of future price of a company’s stock by the expert analysis of investment analysts or investment firms. There may be various price targets for a stock. These analysts and investment firms use various valuation methods to decide a price target for a stock.

Several investment firms issued their expert ratings on TransEnterix, Inc. (NYSE:TRXC) in which Ladenburg Thalmann Downgrades TransEnterix, Inc. (NYSE:TRXC) to Neutral by settling a price target of $4 on 5/29/18. Stifel Nicolaus Maintains the stock to Buy on 10/30/17 by stationing a price target of $4. B. Riley FBR Downgrades the company’s stock to Neutral on 5/11/17 by setting a price target of $0.7. B. Riley FBR Initiates Coverage on TransEnterix, Inc. (NYSE:TRXC) to Buy with no specific Price Target.

TransEnterix, Inc. (NYSE:TRXC) currently has a consensus Price Target of $6.17. While some analysts have a High Price target for the stock of $6.5 and a Low Price Target of $6.

Several sell side analysts reviewed their recommendations on TransEnterix, Inc. (NYSE:TRXC) where 1 analyst have rated the stock as Strong Buy, 1 analysts said it’s a Buy, 3 rated the stock as Hold, 0 analysts reported Underperform and 0 analysts gave their recommendations as Sell. (Current Month Yahoo Finance Ratings)

Zacks Investment Research also rated the stock with a value of 2.5. This scale runs from 1 to 5 where 1 represents Strong Buy and 5 represents Sell.

In the last Quarter, TransEnterix, Inc. (NYSE:TRXC) reported its Actual EPS of $-0.06/share. The analysts offering Earnings Estimates for the company were believing that TransEnterix, Inc. (NYSE:TRXC) could bring EPS of $-0.06/share. The difference between Actual EPS and Estimated EPS was 0 Percent. Thus the company showed an Earnings Surprise of 0 Percent.

TransEnterix, Inc. (NYSE:TRXC) has a market capitalization of 942.95 Million. The stock traded with the volume of 5.16 Million shares in the last trading session. The stock touched its high share price of $6.98 on 09/25/18 and the stock also touched its Lowest price in the last 52-weeks of trading on 02/09/18 as $1.27. The company has a 1 Year high price target of $6.17. The stock is currently trading with a distance of 20-Day Simple Moving Average (SMA20) of -19.6%. The Moving Average SMA50 is -16.69% while SMA200 is 32.32%.

TransEnterix, Inc. (NYSE:TRXC) is currently showing its ROA (Return on Assets) of -64.9%. The Return on Investment (ROI) is at -30.5% while it’s Return on Equity (ROE) value stands at -94.7%. The stock currently shows its YTD (Year to Date) performance of 133.16 percent while its Weekly performance value is -7.6%. The Monthly and Yearly performances are -30.98 percent and 21.95 percent respectively. The Relative Volume value measured for TransEnterix, Inc. (NYSE:TRXC) is 0.81. The Average Volume (3 months) is 6.35 Million.

The stock currently has its Annual Dividend of $0 and an annual Dividend Yield of 0 Percent. TRXC has P/E (Price to Earnings ttm) value of 0, Forward P/E of 0, P/C (Price to cash per share) of 9.81 and Price to Free Cash Flow (P/FCF) value of 0. The stock is showing its Operating Margin of 0 percent.

Company Profile:

TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the development and commercialization of SurgiBot, a patient-side minimally invasive surgical robotic system. TransEnterix Inc., formerly known as SafeStitch Medical, Inc., is based in United States.